...
机译:在HLA-a * 24和-B * 18存在下加速进展到1型糖尿病,仅限于具有不同HLA-DQ和自身抗体风险型材的多个胰岛自身抗体阳性个体
Vrije Univ Brussel Diabet Res Ctr Brussels Belgium;
Vrije Univ Brussel Diabet Res Ctr Brussels Belgium;
Vrije Univ Brussel Diabet Res Ctr Brussels Belgium;
Vrije Univ Brussel Diabet Res Ctr Brussels Belgium;
Vrije Univ Brussel Diabet Res Ctr Brussels Belgium;
Vrije Univ Brussel Diabet Res Ctr Brussels Belgium;
Vrije Univ Brussel Diabet Res Ctr Brussels Belgium;
Vrije Univ Brussel Diabet Res Ctr Brussels Belgium;
Vrije Univ Brussel Diabet Res Ctr Brussels Belgium;
Vrije Univ Brussel Diabet Res Ctr Brussels Belgium;
Vrije Univ Brussel Diabet Res Ctr Brussels Belgium;
Vrije Univ Brussel Diabet Res Ctr Brussels Belgium;
Vrije Univ Brussel Diabet Res Ctr Brussels Belgium;
机译:在HLA-a * 24和-B * 18存在下加速进展到1型糖尿病,仅限于具有不同HLA-DQ和自身抗体风险型材的多个胰岛自身抗体阳性个体
机译:HLA-A * 24是1型糖尿病患者自身抗体阳性一等亲中糖尿病进展5年的独立预测因子
机译:1型糖尿病风险评估:年轻的胰岛自身抗体阳性亲属的随访测量结果有所改善
机译:HLA-A * 24是1型糖尿病患者自身抗体阳性一等亲中糖尿病进展5年的独立预测因子
机译:HLA-A * 24是1型糖尿病患者自身抗体阳性一级亲属的5年糖尿病进展的独立预测因子